NeuroOne Medical Technologies Corporation
NMTC • NASDAQ
NeuroOne Medical Technologies Corporation is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO David A. Rosa, with a market cap of $37.2M.
CEODavid A. Rosa
Next Earnings
Upcoming earnings announcement for NeuroOne Medical Technologies Corporation
Date
Tuesday, May 12, 2026 (in a month)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q2 2026
EPS Estimate
-$0.04
Revenue Estimate
$2.6M
Earnings History
Past 12 earnings reports for NeuroOne Medical Technologies Corporation
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 17, 2026 | Q1 2026 | -$0.03Est: -$0.04 | +25.0% | $2.9MEst: $2.7M | +8.8% |  10-Q |
| Dec 17, 2025 | Q4 2025 | -$0.04Est: -$0.04 | 0.0% | $2.7MEst: $2.5M | +11.0% | 10-K/A |
| Aug 14, 2025 | Q3 2025 | -$0.03 | — | $1.7MEst: $1.8M | -6.8% | 10-Q |
| May 13, 2025 | Q2 2025 | -$0.07Est: $0.00 | — | $1.4MEst: $1.3M | +9.2% | 10-Q |
| Feb 12, 2025 | Q1 2025 | $0.06 | — | $3.3M | — | 10-Q |
| Dec 17, 2024 | Q4 2024 | -$0.11 | — | $272.3K | — | 10-K |
| Aug 14, 2024 | Q3 2024 | -$0.10Est: -$0.10 | 0.0% | $825.8KEst: $2.0M | -58.7% | 10-Q |
| May 14, 2024 | Q2 2024 | -$0.11Est: -$0.10 | -10.0% | $1.4MEst: $1.7M | -19.0% | 10-Q |
| Feb 13, 2024 | Q1 2024 | -$0.14Est: -$0.14 | 0.0% | $977.6KEst: $850.0K | +15.0% | 10-Q |
| Dec 14, 2023 | Q4 2023 | -$0.13Est: -$0.17 | +23.5% | $741.8KEst: $800.0K | -7.3% | — |
| Aug 14, 2023 | Q3 2023 | -$0.20Est: -$0.20 | 0.0% | $629.9KEst: $350.0K | +80.0% | — |
| May 11, 2023 | Q2 2023 | -$0.21Est: -$0.20 | -5.0% | $466.2KEst: $250.0K | +86.5% | — |